REG - Compre Group Hldgs - Compre acquires further MedMal portfolio

Marsh & McLennan CompaniesAnnouncement

25/08/2022 09:30

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220825:nRSY2089Xa&default-theme=true

RNS Number : 2089X  Compre Group Holdings Limited  25 August 2022

 

 

 

Press release

25 August 2022

 

Compre acquires further MedMal portfolio

 

Compre Group Holdings Limited ("Compre"), the Bermuda headquartered
international legacy group, today announces it has received regulatory
approval to acquire the French medical malpractice ("MedMal") portfolio from a
European based insurer for an undisclosed sum.

 

The deal, structured as a loss portfolio transfer to be followed by a legal
transfer, is a further significant transaction that supports Compre's ambition
to build a centre of excellence for MedMal in Europe. The portfolio contains
legacy, live and prospective risks through 2023. The transaction was brokered
by Guy Carpenter.

 

Simon Hawkins, CEO Europe said: "I am delighted to announce our second
acquisition of European MedMal legacy liabilities. We worked closely with the
insurer to ensure the structure optimises capital release and provides
operational finality. This transaction further demonstrates our client-focused
approach, which ensured our client's objectives were realised, and our
commitment to building a centre of excellence for MedMal in Europe."

 

- Ends -

For further information please contact:

Compre

David Haggie / Richard Adams / Olivia Thomson, Haggie
Partners

+44 20 7562 4444

 

About Compre:

Compre is a leading legacy specialist with over 30 years of experience in the
acquisition and management of discontinued and legacy non-life insurance and
reinsurance business. Compre has experience of acquiring most classes of
direct and reinsurance business, including general liability, marine and motor
liability, and US APH. Compre has operations in Bermuda, Finland, Germany,
Malta, Switzerland, the UK, US and at Lloyd's of London.

 

www.compre-group.com (http://www.compre-group.com)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  CIREAXPSAAEAEEA